Samsung Biologics Co Ltd (207940) earningsupdated Nov 22 13:07 UTC
Q4 2026Jan 20, 2027est 10,195.26Pending
Q3 2026Nov 16, 20268,458.00−13.7%
Q3 2026Oct 27, 20268,458.00−13.7%
Q2 2026Aug 14, 20269,314.00−5.7%
Q1 2026May 15, 202610,148.00+6.3%
Q4 2025Feb 25, 20268,723.00−23.4%
Next report: Wed Jan 20, 2027, BMO